A third top doctor has died from Ebola in Sierra Leone, a government official said Wednesday, as health workers tried to determine how a fourth scientist also contracted the disease before being evacuated to Europe.
Japanese health authorities have reported the first locally transmitted case of dengue fever in...
The TIM family of proteins that promotes virus entry into cells also has the ability to block...
A Liberian doctor who was among three Africans to receive an experimental Ebola drug has died,...
Two American aid workers have recovered from Ebola and left an Atlanta hospital, after weeks of intensive treatment in a special isolation unit. They were first two Ebola patients ever brought to the United States.
New research suggests a one-two punch could help battle polio in some of the world's most remote and strife-torn regions: Giving a single vaccine shot to children who've already swallowed drops of an oral polio vaccine greatly boosted their immunity.
Scientists who study tuberculosis have long debated its origins. New research shows that tuberculosis likely spread from humans in Africa to seals and sea lions that brought the disease to South America and transmitted it to Native people there before Europeans landed on the continent.
After nearly three weeks of treatment, the two American aid workers who were infected with the deadly Ebola virus in Africa have been discharged from an Atlanta hospital, officials said Thursday.
The enzyme phospholipase D (PLD) helps the influenza virus escape the immune response, and blocking it could lead to a new way to prevent the flu.
Scientists have made a breakthrough in the fight against the most resistant hospital superbugs by developing the first innovative antibacterial gel that acts to kill Pseudomonas aeruginosa, staphylococci and E. coli, using natural proteins.
The U.N. health agency says the Ebola outbreak in West Africa has now killed more than 1,200 people. The World Health Organization says the death toll has risen to 1,229 from among the 2,240 reported cases in Guinea, Liberia, Nigeria and Sierra Leone.
An estimated 55 million to 105 million people in the United States suffer from foodborne illnesses each year, according to the CDC, resulting in costs of $2 to $4 billion annually. What if Twitter could be used to track those cases and more quickly identify the source of the problem?
New research found that receiving antibiotic treatments early in life can increase susceptibility to specific diseases later on. The study helps scientists understand how different antibiotics affect good bacteria.
A scary problem lurks beyond the frenzied efforts to keep people from spreading Ebola: No one knows exactly where the virus comes from or how to stop it from seeding new outbreaks.
An investigation into a potentially dangerous blunder at a government lab found that a scientist kept silent about the accident and revealed it only after other employees noticed something fishy.
It's an eye-catching angle in the story of an experimental treatment for Ebola: The drug comes from tobacco plants that were turned into living pharmaceutical factories. Using plants this way — sometimes called "pharming" — can produce complex and valuable proteins for medicines.
An Iowa drug developer says it has enough doses of a possible vaccine for the deadly Ebola virus to launch an initial round of human testing. NewLink Genetics Chief Financial Officer Gordon Link says the timing of the trials is uncertain, but the company is receiving help from a number of sources to speed up the process.
A leading physician in Sierra Leone's fight against Ebola has died from the disease, an official said Wednesday, as it emerged that another top doctor had been considered to receive an experimental drug but did not get it and later died.
Plasmodium falciparum, the parasite that causes malaria, has proven notoriously resistant to scientists’ efforts to study its genetics. It can take up to a year to determine the function of a single gene, which has slowed efforts to develop new, more targeted drugs and vaccines.
A Spanish missionary priest being treated for Ebola died Tuesday in a Madrid hospital amid a worldwide debate over who should get experimental Ebola treatments. After holding a teleconference with medical experts around the world, the WHO declared it is ethical to use unproven Ebola drugs and vaccines in the current outbreak.
Wrapping wound dressings around fingers and toes can be tricky, but for burn victims, guarding them against infection is critical. Today, scientists are reporting the development of novel, ultrathin coatings called nanosheets that can cling to the body’s most difficult-to-protect contours and keep bacteria at bay.
The World Health Organization on Friday declared the Ebola outbreak in West Africa to be an international public health emergency that requires an extraordinary response to stop its spread. The WHO announced the Ebola outbreak — the largest and longest in history — is worrying enough to merit being declared an international health emergency. WHO declared similar emergencies for the swine flu pandemic in 2009 and for polio in May.
Thinking about getting inked? Check the bottle first. The Food and Drug Administration is warning tattoo parlors, their customers and those buying at-home tattoo kits that not all tattoo ink is safe.
There is good news in attempts to halt HIV by growing, in patients, new immune systems lacking a gene that led to the first—and only—cured HIV patient. Using hematopoietic (blood) stem cells possessing a CCR5 gene mutation that blocks CD4 T cell entry of HIV, Calimmune—led by Nobel Laureate David Baltimore—has, for one year, safely begun growing new immune systems in patients.
Effective new drugs and screening would make hepatitis C a rare disease by 2036, according to a computer simulation conducted by The University of Texas MD Anderson Cancer Center and the University of Pittsburgh Graduate School of Public Health.
University of Michigan Health System researchers revealed an obesity paradox among older Americans suffering from sepsis. In a study of 1,404 Medicare beneficiaries, heavier patients were more likely to survive the life-threatening infection that can lead to a stay in a hospital’s intensive care unit.
The body’s assailants are cleverer than previously thought. New research from Lund University in Sweden shows for the first time how bacteria in the airways can help each other replenish vital iron. The bacteria thereby increase their chances of survival, which can happen at the expense of the person’s health.
A water ban that had hundreds of thousands of people in Ohio and Michigan scrambling for drinking water has been lifted, Toledo's mayor announced Monday.
The nation's top infectious disease official says there's hope that a vaccine against Ebola will be available as early as next July. Dr. Anthony Fauci of the National Institutes of Health says such a preventive vaccine has been successfully tested with monkeys.
- Page 1